Shares of Bioanalytical Systems traded down $0.02, hitting $1.64, on Wednesday, MarketBeat reports. 300 shares of the stock traded hands, compared to its average volume of 28,018. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.72 and a quick ratio of 0.59. Bioanalytical Systems has a twelve month low of $1.76 and a twelve month high of $1.83.
Bioanalytical Systems (NASDAQ:BASI) last issued its quarterly earnings data on Tuesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $5.94 million for the quarter. Bioanalytical Systems had a net margin of 2.35% and a return on equity of 6.39%.
Bioanalytical Systems Company Profile
Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through Contract Research Services and Research Products segments.
Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with MarketBeat.com's FREE daily email newsletter.